Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Copolov

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Australian and New Zealand Journal of Psychiatry|July 7, 2021
Re-balancing Victorian psychiatric services: Will increasing the supply of community services impact upon hospital demand?Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, et al.
Psychiatry Research|February 17, 2020
Corrigendum to 'Have we overlooked the significance of multinodal hallucinations in schizophrenia?' [Psychiatry Research 279 (2019) 358-360]Wei Lin Toh, Simon McCarthy-Jones, David Copolov, et al.
Psychiatry Research|August 30, 2005
EEG coherence measures during auditory hallucinations in schizophreniaAnusha Sritharan, Per Line, Alex Sergejew, et al.
CNS Drugs|April 5, 2020
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for SchizophreniaNicholas Keks, Judith Hope, Darren Schwartz, et al.
The Australian and New Zealand Journal of Psychiatry|May 11, 2021
Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?Tarun Bastiampillai, Sherry Kit Wa Chan, Stephen Allison, et al.
The Australian and New Zealand Journal of Psychiatry|August 22, 2020
Jumping off the bandwagon: Does the Basaglian de-hospitalised model work outside Trieste?Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, et al.
Journal of Clinical Psychology|April 26, 2007
The voices acceptance and action scale (VAAS): Pilot dataFrances Shawyer, Kirk Ratcliff, Andrew Mackinnon, et al.
Monash Bioethics Review|April 9, 2004
How can valid informed consent be obtained from a psychotic patient for research into psychosis? Three perspectivesIan Freckelton, Nicholas Keks, Vivienne Howe, et al.
BMC Psychiatry|July 13, 2014
A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocolNeil Thomas, Frances Shawyer, David J Castle, et al.
Human Psychopharmacology|December 7, 2011
Who's left? Symptoms of schizophrenia that predict clinical trial dropoutJason Thompson, Michael Berk, Olivia Dean, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Australian and New Zealand Journal of Psychiatry|July 7, 2021
Re-balancing Victorian psychiatric services: Will increasing the supply of community services impact upon hospital demand?Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, et al.
Psychiatry Research|February 17, 2020
Corrigendum to 'Have we overlooked the significance of multinodal hallucinations in schizophrenia?' [Psychiatry Research 279 (2019) 358-360]Wei Lin Toh, Simon McCarthy-Jones, David Copolov, et al.
Psychiatry Research|August 30, 2005
EEG coherence measures during auditory hallucinations in schizophreniaAnusha Sritharan, Per Line, Alex Sergejew, et al.
CNS Drugs|April 5, 2020
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for SchizophreniaNicholas Keks, Judith Hope, Darren Schwartz, et al.
The Australian and New Zealand Journal of Psychiatry|May 11, 2021
Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?Tarun Bastiampillai, Sherry Kit Wa Chan, Stephen Allison, et al.
The Australian and New Zealand Journal of Psychiatry|August 22, 2020
Jumping off the bandwagon: Does the Basaglian de-hospitalised model work outside Trieste?Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, et al.
Journal of Clinical Psychology|April 26, 2007
The voices acceptance and action scale (VAAS): Pilot dataFrances Shawyer, Kirk Ratcliff, Andrew Mackinnon, et al.
Monash Bioethics Review|April 9, 2004
How can valid informed consent be obtained from a psychotic patient for research into psychosis? Three perspectivesIan Freckelton, Nicholas Keks, Vivienne Howe, et al.
BMC Psychiatry|July 13, 2014
A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocolNeil Thomas, Frances Shawyer, David J Castle, et al.
Human Psychopharmacology|December 7, 2011
Who's left? Symptoms of schizophrenia that predict clinical trial dropoutJason Thompson, Michael Berk, Olivia Dean, et al.
Pageof 5